Skip to content

Effect of Dexmedetomidine Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients

Effect of Dexmedetomidine Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004837
Enrollment
Unknown
Registered
2014-04-05
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperalgesia

Interventions

contorl:Normal saline is intravenously administrated before anesthesia induction
Dexmedetomidine group (Dex):Dexmedetomidine is intravenously administrated at a dose of 1.0µg/ kg at 10 min intervals before anesthesia induction, remifentanil maintenance at a dose of 0.3µg/kg·min
Flurbiprofen axetil group I:Flurbiprofen axetil is intravenously administrated at a dose of 1.5mg/ kg before anesthesia induction, remifentanil maintenance at a dose of 0.3µg/kg.min
Flurbiprofen axetil group II (Flu II):Flurbiprofen axetil is intravenously administrated at a dose of 1.5mg/ kg before 15 minutes completion of surgery, remifentanil maintenance at a dose of 0.3µg·kg·
Dexmedetomidine combined Flurbiprofen axetil group:Dexmedetomidine is intravenously administrated at a dose of 1.0µg/ kg at 10 min intervals and Flurbiprofen axetil is intravenously administrated at a
Dexmedetomidine combined Flurbiprofen axetil group:Dexmedetomidine is intravenously administrated at a dose of 1.0µg/ kg at 10 min intervals before anesthesia induction, and Flurbiprofen axetil is int

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Upon approval of the ethics committee at our hospital, the patients or their family members have signed informed consent. ASA I - II class undergoing elective surgery patients, 180 cases of laparoscopic cholecystectomy, aged 18 to 60. There is no history of using long-term opioid drugs and narcotics.

Exclusion criteria

Exclusion criteria: Dexmedetomidine and flurbiprofen axetil allergies, clinical severe liver and kidney disease or mental illness, pregnant woman, with alcohol or drug abuse ,history of using containing ingredients of opioid analgesic or sedative ,any contraindication for the use of patient-controlled analgesia (PCA).

Design outcomes

Primary

MeasureTime frame
Pain threshold;Cumulative sufentanyl consumption;

Secondary

MeasureTime frame
Visul Analog Scale;Time of first postoperative analgesic requiremen;

Contacts

Public ContactShiyuan XU

The Department of Anesthesiology, Nanfang Hospital

Xushiyuan335@163.com+86 13609727860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026